Adherencia al tratamiento farmacológico en pacientes con patologías urológicas atendidos en el Hospital Nacional PNP Luis N. SÁENZ, Lima – 2025
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Privada de Huancayo Franklin Roosevelt
DOI
Abstract
La investigación tuvo como objetivo evaluar la adherencia al tratamiento farmacológico en pacientes con patologías urológicas del Hospital Nacional PNP Luis N. Sáenz, durante 2025. Se realizó un estudio cuantitativo, descriptivo y transversal, con una muestra de 322 pacientes, utilizando un cuestionario adaptado del MMAS-8. Los resultados evidenciaron que el 57,8 % presentó baja adherencia, el 31,4 % media y el 10,9 % alta. Además, se identificaron barreras importantes para el cumplimiento terapéutico. Se concluyó que predomina una baja adherencia, por lo que se requiere fortalecer la educación sanitaria y el seguimiento farmacoterapéutico.
The objective of this research was to evaluate adherence to pharmacological treatment among patients with urological conditions at the Luis N. Sáenz PNP National Hospital during 2025. A quantitative, descriptive, cross-sectional study was conducted with a sample of 322 patients, using a questionnaire adapted from the MMAS-8. The results showed that 57.8% of patients exhibited low adherence, 31.4% moderate adherence, and 10.9% high adherence. Furthermore, significant barriers to therapeutic compliance were identified. It was concluded that low adherence is the predominant pattern, highlighting the need to strengthen health education and pharmacotherapeutic monitoring.
The objective of this research was to evaluate adherence to pharmacological treatment among patients with urological conditions at the Luis N. Sáenz PNP National Hospital during 2025. A quantitative, descriptive, cross-sectional study was conducted with a sample of 322 patients, using a questionnaire adapted from the MMAS-8. The results showed that 57.8% of patients exhibited low adherence, 31.4% moderate adherence, and 10.9% high adherence. Furthermore, significant barriers to therapeutic compliance were identified. It was concluded that low adherence is the predominant pattern, highlighting the need to strengthen health education and pharmacotherapeutic monitoring.
Description
Citation
Vancouver
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2
